摘要
过去几年里,作为能够揭示在体内种群动态和等级关系的独特技术,克隆追踪已获得万众瞩目。在这里我们强调了主要的有关造血细胞在体内克隆行为的悬而未决的问题,特别关注作为细胞和基因治疗的主要靶点的造血干细胞和祖细胞以及T细胞。我们粗略地筛查了目前适用于在动物模型跟踪造血细胞在体内的动态和功能的方法,描述了在人体早期研究的结果。我们特别关注了最近使用的逆转录病毒和慢病毒载体整合位点(IS)分析,以跟随体内稳定标记的克隆和它们的后代。我们表明这种分子跟踪方法如何可以成功地应用在人体研究以揭示造血细胞的克隆行为,描述了从基因治疗的患者的样本里进行的开创性的研究工作。通过整合位点识别的克隆跟踪仍然是一个复杂的未成熟的实验方案和有技术/分析方面的限制。在这方面,我们回顾了可用于整合位点的识别和定量的计算工具的特征,因为这项技术正在成为人类工程细胞在体内的命运和生存的信息的主要来源,我们强调了基于IS的跟踪技术在将来改进的可能。
关键词: 克隆跟踪,造血干细胞,T细胞,整合位点分析。
Current Gene Therapy
Title:Current Approaches and Future Perspectives for In Vivo Clonal Tracking of Hematopoietic Cells
Volume: 16 Issue: 3
Author(s): Serena Scala, Lorena Leonardelli, Luca Biasco
Affiliation:
关键词: 克隆跟踪,造血干细胞,T细胞,整合位点分析。
摘要: Over the past years, clonal tracking has gained the center stage as a unique technology capable to unveil population dynamics and hierarchical relationships in vivo. We here highlighted the main open questions related to the in vivo clonal behavior of hematopoietic cells with a particular focus on hematopoietic stem and progenitor cells and T cells as main targets of cell- and gene-therapies. We walked through the current methods applied for tracing in vivo dynamics and functions of hematopoietic cells in animal models and we described the results of early studies conducted on humans. We specifically focused our attention on the recent use of retroviral/lentiviral vector Integration Site (IS) analyses to follow stably marked clones and their progeny in vivo. We showed how this molecular tracking method can be successfully employed in human studies to unveil the clonal behavior of hematopoietic cells, describing pioneering works conducted on samples from gene therapy treated patients. Clonal tracking through IS identification still comes with a complex wet-experimental protocol and technical/analytical constraints. In this regard, we reviewed the features of the available computational tools for the identification and quantification of ISs and we highlighted the potential future improvements of IS-based tracking, as this technology is becoming a major source of information on in vivo fate and survival of engineered cells in humans.
Export Options
About this article
Cite this article as:
Serena Scala, Lorena Leonardelli, Luca Biasco , Current Approaches and Future Perspectives for In Vivo Clonal Tracking of Hematopoietic Cells, Current Gene Therapy 2016; 16 (3) . https://dx.doi.org/10.2174/1566523216666160428104456
DOI https://dx.doi.org/10.2174/1566523216666160428104456 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements